Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Ideal for researchers investigating senescence pathways, FOXO4-p53 signaling, and cellular aging mechanisms
The medication is not suitable for individuals with type 1 diabetes or diabetic ketoacidosis, and careful consideration is required in those with a history of pancreatitis or severe gastrointestinal disease
DSIP Peptide | Buy DSIP UK | Research Use Only DSIP Delta Sleep-Inducing Peptide is a naturally occurring amphiphilic nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, MW 849 Da) first isolated from rabbit cerebral venous blood in 1977 by the Schoenenberger-Monnier group at the University of Basel, found in both free and bound forms in the hypothalamus, limbic system, pituitary, gut, pancreas, and body fluids, that in pre-clinical and limited clinical research demonstrates a uniquely broad neuromodulatory profile promoting delta-wave slow-wave sleep (SWS), modulating corticotropin and GH release, exerting stress-protective and adaptogenic activity, reducing mitochondrial oxidative stress under hypoxia, demonstrating anticonvulsant and antinociceptive activity, accelerating motor research applications post-stroke, and exhibiting geroprotective and anticarcinogenic properties in long-term murine studies making it one of the most pharmacologically diverse endogenous regulatory neuropeptides in the sleep and stress research literature, despite its receptor remaining formally unidentified
Chronic myelogenous leukemia, promyelocytic leukemia, polycythemia vera and hypereosinophilic syndrome have all been associated with high B12 levels (25)
